Key result
Intramyocardial transplantation of hUCB-derived CD45- Lin- cells in rats after reperfused myocardial infarction improved left ventricular function and remodeling compared with vehicle.
Why the study?
Whether human umbilical cord blood-derived nonhematopoietic cells would induce cardiac repair remained unknown.
Does intramyocardial transplantation of hUCB-derived CD45- Lin- cells improve left ventricular function and remodeling in rats after myocardial ischemia/reperfusion?
Does intramyocardial transplantation of hUCB-derived CD45- Lin- cells improve left ventricular function and remodeling in rats after myocardial ischemia/reperfusion?
Intramyocardial transplantation of human umbilical cord blood-derived nonhematopoietic cells improves cardiac function and remodeling in a rat model of ischemia/reperfusion via paracrine mechanisms.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for hUCB-derived cell therapy in reperfused MI; human translation unproven.
Rationale: Human umbilical cord blood (hUCB) contains diverse populations of stem/progenitor cells. Whether hUCB-derived nonhematopoietic cells would induce cardiac repair remains unknown. Objective: To examine whether intramyocardial transplantation of hUCB-derived CD45 − Lin − nonhematopoietic cellular fraction after a reperfused myocardial infarction in nonimmunosuppressed rats would improve cardiac function and ameliorate ventricular remodeling. Methods and Results: Nonhematopoietic CD45 − Lin − cells were isolated from hUCB. Flow cytometry and quantitative polymerase chain reaction were used to characterize this subpopulation. Age-matched male Fischer 344 rats underwent a 30-minute coronary occlusion followed by reperfusion and 48 hours later received intramyocardial injection of vehicle or hUCB CD45 − Lin − cells. After 35 days, compared with vehicle-treated rats, CD45 − Lin − cell–treated rats exhibited improved left ventricular function, blunted left ventricular hypertrophy, greater preservation of viable myocardium in the infarct zone, and superior left ventricular remodeling. Mechanistically, hUCB CD45 − Lin − cell injection favorably modulated molecular pathways regulating myocardial fibrosis, cardiomyocyte apoptosis, angiogenesis, and inflammation in postinfarct ventricular myocardium. Rare persistent transplanted human cells could be detected at both 4 and 35 days after myocardial infarction. Conclusions: Transplantation of hUCB-derived CD45 − Lin − nonhematopoietic cellular subfraction after a reperfused myocardial infarction in nonimmunosuppressed rats ameliorates left ventricular dysfunction and improves remodeling via favorable paracrine modulation of molecular pathways. These findings with human cells in a clinically relevant model of myocardial ischemia/reperfusion in immunocompetent animals may have significant translational implications.Visual Overview: An online visual overview is available for this article.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2019) studied Myocardial infarction (ischemia/reperfusion). Intramyocardial transplantation of hUCB-derived CD45- Lin- nonhematopoietic cellular fraction vs. Vehicle was evaluated on Left ventricular function and remodeling. Intramyocardial transplantation of hUCB-derived CD45- Lin- cells in rats after reperfused myocardial infarction improved left ventricular function and remodeling compared with vehicle.
Synapse has enriched 10 related papers. Consider them for comparative context: